- Home
- SWIN vs PYPD Comparison
SWIN vs PYPD Comparison
Compare SWIN & PYPD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SWIN
- PYPD
- Stock Information
- Founded
- SWIN 2017
- PYPD 2008
- Country
- SWIN Hong Kong
- PYPD Israel
- Employees
- SWIN N/A
- PYPD N/A
- Industry
- SWIN
- PYPD Medical/Dental Instruments
- Sector
- SWIN
- PYPD Health Care
- Exchange
- SWIN Nasdaq
- PYPD Nasdaq
- Market Cap
- SWIN 32.1M
- PYPD 26.7M
- IPO Year
- SWIN 2023
- PYPD 2020
- Fundamental
- Price
- SWIN $1.57
- PYPD $3.27
- Analyst Decision
- SWIN
- PYPD Strong Buy
- Analyst Count
- SWIN 0
- PYPD 4
- Target Price
- SWIN N/A
- PYPD $10.25
- AVG Volume (30 Days)
- SWIN 265.3K
- PYPD 72.8K
- Earning Date
- SWIN 06-17-2025
- PYPD 05-14-2025
- Dividend Yield
- SWIN N/A
- PYPD N/A
- EPS Growth
- SWIN N/A
- PYPD N/A
- EPS
- SWIN N/A
- PYPD N/A
- Revenue
- SWIN $2,419,000.00
- PYPD N/A
- Revenue This Year
- SWIN N/A
- PYPD N/A
- Revenue Next Year
- SWIN $61.68
- PYPD N/A
- P/E Ratio
- SWIN N/A
- PYPD N/A
- Revenue Growth
- SWIN N/A
- PYPD N/A
- 52 Week Low
- SWIN $1.16
- PYPD $2.30
- 52 Week High
- SWIN $5.33
- PYPD $4.49
- Technical
- Relative Strength Index (RSI)
- SWIN 45.14
- PYPD 64.41
- Support Level
- SWIN $1.58
- PYPD $2.98
- Resistance Level
- SWIN $1.85
- PYPD $3.30
- Average True Range (ATR)
- SWIN 0.21
- PYPD 0.24
- MACD
- SWIN -0.01
- PYPD 0.05
- Stochastic Oscillator
- SWIN 38.33
- PYPD 95.40
About SWIN Solowin Holdings
Solowin Holdings Ltd is a investor-focused, versatile securities brokerage company in Hong Kong. It offers a wide spectrum of products and services through its secured one-stop electronic platform. It is engaged in providing securities related services, investment advisory service, and asset management service to customers. The operations were organized into four reportable segments: securities related services, investment advisory services, corporate consultancy services, and asset management services. It derives maximum revenue from investment advisory services.
About PYPD PolyPid Ltd.
PolyPid Ltd is a clinical-stage biopharmaceutical company engaged in the research and development of products based on PLEX (Polymer-Lipid Encapsulation MatriX), the company's proprietary drug delivery technology. PLEX is capable of encapsulating many types of drugs to enable targeted, localized drug delivery into the body over extended periods of time with pre-determined release rates thus optimizing drug treatment regimens. BonyPid, PolyPid, Opzifend, Ssisurg, Elyfssi, Baczenssi, Opzifend and Bacyssio are trademarks of the company. Its product candidate include D-PLEX100 for prevention of SSI in soft tissue and OncoPLEX which can be a potential Intra-tumoral therapy.